Making a business case for integrating multidimensional sustainability in the pharmaceutical industry

Show simple item record

dc.contributor.advisor Wadhams, Jennifer en_US
dc.contributor.author Jung, Thea
dc.date.accessioned 2012-04-09T19:51:40Z
dc.date.available 2012-04-09T19:51:40Z
dc.date.issued 2002
dc.identifier.uri http://hdl.handle.net/1850/14919
dc.description.abstract To grow their bottom lines, companies invest in business value drivers. This thesis examined whether multidimensional sustainability performance could be one of those drivers in the pharmaceutical industry. There are currently very few (if any) mandatory requirements for integrating multidimensional sustainability. Nor are there standardized methods of integrating, measuring, or communicating multidimensional sustainability. This thesis reviewed, compared, and contrasted (also known as benchmarking) voluntary sustainability initiatives and pharmaceutical company sustainability initiatives. The results were as follows: 1) the concept of multidimensional sustainability is generally understood; 2) integrating multidimensional sustainability is the morally and ethically correct action for pharmaceutical companies to take; 3) research is insufficient to support the relationship between integrating sustainability and driving business value in the pharmaceutical industry; and 4) pharmaceutical companies taking action to integrate multidimensional sustainability are reaping significant business value added. This thesis also discusses the reasons for and methods of measuring and reporting multidimensional sustainability performance, the elements required for successful integration of multidimensional sustainability in the pharmaceutical industry, and the steps necessary to integrate multidimensional sustainability throughout a pharmaceutical company. en_US
dc.language.iso en_US en_US
dc.subject Bottom line en_US
dc.subject Environment en_US
dc.subject Health en_US
dc.subject Integration en_US
dc.subject Multidimensional en_US
dc.subject People en_US
dc.subject Pharmaceutical industry en_US
dc.subject Planet en_US
dc.subject Profits en_US
dc.subject Safety en_US
dc.subject Sustainable development en_US
dc.subject.lcc HD9665.5 .J864 2002
dc.subject.lcsh Pharmaceutical industry--Environmental aspects
dc.subject.lcsh Sustainable development
dc.title Making a business case for integrating multidimensional sustainability in the pharmaceutical industry en_US
dc.type Thesis en_US
dc.description.college College of Applied Science and Technology en_US
dc.description.department Department of Environmental Management and Safety Program en_US

Files in this item

Files Size Format View
TJungThesis06-2002.pdf 51.41Mb PDF View/Open

This item appears in the following Collection(s)

Show simple item record

Search RIT DML


Advanced Search

Browse